High-fructose corn syrup aggravates colitis via microbiota dysbiosis-mediated Th17/Treg imbalance
Clinical Science · 2023
DOI: 10.1042/cs20230788 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Science, 2023. Verfasst von Mingxia Zhou und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Colitis, Microbiota, Inflammatory Bowel Diseases. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 2.0). Gefördert von: Natural Science Foundation of China, Shanghai Yangpu District Science and Technology Commission and Health and Family Planning Commission.
Abstract (Originalsprache)
Dietary fructose is widely used in beverages, processed foods, and Western diets as food additives, and is closely related to the increased prevalence of multiple diseases, including inflammatory bowel disease (IBD). However, the detailed mechanism by which high fructose disrupts intestinal homeostasis remains elusive. The present study showed that high-fructose corn syrup (HFCS) administration exacerbated intestinal inflammation and deteriorated barrier integrity. Several in vivo experimental models were utilized to verify the importance of gut microbiota and immune cells in HFCS-mediated dextran sulfate sodium (DSS)-induced colitis. In addition, untargeted metabolomics analysis revealed the imbalance between primary bile acids (PBAs) and secondary bile acids (SBAs) in feces. Hence, high fructose was speculated to modulate gut microbiota community and reduced the relative abundance of Clostridium and Clostridium scindens at genus and species level respectively, followed by a decrease in SBAs, especially isoalloLCA, thereby affecting Th17/Treg cells equilibrium and promoting intestinal inflammation. These findings provide novel insights into the crosstalk between gut flora, bile acids, and mucosal immunity, and highlight potential strategies for precise treatment of IBD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
- Department of Gastroenterology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
- Shanghai Key Laboratory of Pediatric Gastroenterology and Nutrition, Shanghai, China.
- Department of Breast Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
- Department of Medical Laboratory, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
- Department of Gastroenterology, Kongjiang Hospital of Yangpu District, Shanghai, China.
ORCID-Profile: Yingwei Chen
Förderung
- Natural Science Foundation of China
- Shanghai Yangpu District Science and Technology Commission and Health and Family Planning Commission
Zitieren
APA
Zhou, M., Liu, X., He, J., Xu, X., Ju, C., Luo, S., Lu, X., Du, P., & Chen, Y. (2023). High-fructose corn syrup aggravates colitis via microbiota dysbiosis-mediated Th17/Treg imbalance. Clinical Science. https://doi.org/10.1042/cs20230788
Vancouver
Zhou M, Liu X, He J, Xu X, Ju C, Luo S, et al. High-fructose corn syrup aggravates colitis via microbiota dysbiosis-mediated Th17/Treg imbalance. Clinical Science. 2023. doi:10.1042/cs20230788
BibTeX
@article{Zhou2023,
author = {Zhou, Mingxia and Liu, Xiaoman and He, Jing and Xu, Xinyu and Ju, Chenxi and Luo, Shangjian and Lu, Xiajuan and Du, Peng and Chen, Yingwei},
title = {High-fructose corn syrup aggravates colitis via microbiota dysbiosis-mediated Th17/Treg imbalance},
journal = {Clinical Science},
year = {2023},
doi = {10.1042/cs20230788}
}
EUVIMED